Abstract OBJECTIVE: To study the roles of serum and urinary interleukins (IL)-13Rα2, IL-4, IL-6, IL8 and tumor necrosis factor-α(TNF-α) in pediatric Henoch-Schonlein purpura (HSP). METHODS: Serum and urinary levels of IL-13Rα2, IL-4, IL-6, IL-8 and TNF-α were examined using ELISA in 52 children with HSP and 45 healthy children. The results were compared between the two groups. RESULTS: Serum levels of IL-13Rα2, IL-4, IL-6, IL-8 and TNF-α in HSP patients with or without renal lesions were higher than those in the control group (P< 0.01 or 0.05). Urinary levels of IL-6 and TNF-α in HSP patients without renal lesions were higher than those in the control group (P<0.05). Except for urinary levels of IL-6 and TNF-α, urinary IL-13Rα2 levels in HSP patients with renal lesions (HSPN) were higher than those in the control group (P<0.05 ). CONCLUSIONS: Cytokines IL-13Rα2, IL-4, IL-6, IL-8 and TNF-α may play roles in the pathogenesis of pediatric HSP/HSPN.［Chin J Contemp Pediatr, 2009, 11 (1):37-40］
YU Yan-Hong,PAN Kai-Li,LI Qi et al. Roles of serum and urinary interleukins 13Rα2 and other cytokines in pediatric Henoch-Schonlein purpura[J]. 中国当代儿科杂志, 2009, 11(01): 37-40.
YU Yan-Hong,PAN Kai-Li,LI Qi et al. Roles of serum and urinary interleukins 13Rα2 and other cytokines in pediatric Henoch-Schonlein purpura[J]. CJCP, 2009, 11(01): 37-40.
［4］Tahan F, Dursun I, Poyrazoglu H, Gurgoze M, Dusunsel R. The role of chemokines in Henoch Schonlein Purpura［J］.Rheumatology Int, 2007, 27（10）：955-960.
［10］Fukatsu A, Matsuo S, Tamai H, Sakamoto N, Matsuda T, Hirano T. Distribution of interleukin-6 in normal and diseased human kidney［J］. Lab Invest, 1991, 65(1):61-66.
［11］Watts RA, Scott DG. Epidemiology of the vasculities［J］. Curr Opin Rheumatol, 2003, 15(1):11-16.
［12］Yang YH, Lai HJ, Huang CM, Wang LC, Lin YT, Chiang BL. Sera from children with active Henoch-Schonlein purpura can enhance the production of interleukin 8 by human umbilical venous endothelial cells［J］. Ann Rheum Dis, 2004, 63(11)：1511-1513.
［13］Ozaltin F, Bakkaloglu A, Ozen S, Topaloglu R, Kavak U, Kalyoncu M, et al. The significance of IgA class of antineutrophil cytoplasmic antibodies (ANCA) in childhood Henoch-Schonlein purpura［J］. Clin Rheumatol, 2004, 23(5)：426-429.
［14］Bertani T, Abbate M, Zoja C, Corna D, Perico N, Ghezzi P. Tumor necrosis factor induces glomerular damage in the rabbit［J］. Am J Pathol, 1989, 134(2):419-430.
［15］Ozen S, Saatci U, Tinaztepe K, Bakkaloglu A, Barut A. Urinary tumor necrosis factor levels in primary glomerulopathies［J］.Nephron, 1994, 66(3):291-294.
［16］Tsuji Y, Abe Y, Hisano M, Sakai T. Urinary leukotriene E4 in Henoch-Schonlein purpura［J］. Clin Exp Allergy, 2004, 34(8)：1259-1261.
［17］Ha TS. The role of tumor necrosis factor-alpha in Henoch-Schonlein purpura［J］.Pediatr Nephrol, 2005, 20(2):149-153.
［19］Kimata H, Hujimoto M, Furusho K.Involvement of interleukin (IL)-13, but not IL-4, in spontaneous IgE and IgG4 production in nephrotic syndrome［J］. Eur J Immunol, 1995, 25(6):1497-1501.
［20］Bernard J, Treton D, Vermot-Desroches C, Boden C, Horellou P, Angevin E, et al. Expression of interleukin 13 receptor in glioma and renal cell carcinoma: IL13R alpha 2 as a decoy receptor for IL13［J］.Lab Invest, 2001, 81(9)：1223-1231.
